Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

RDInvesting Provides Investors with Free In-Depth Equity Reports on HOS, NEPT, RNN and SN

OCUP, NEPTF

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Hornbeck Offshore Services, Inc. (NYSE: HOS) shares increased 1.11 percent to close at $58.49 a share Tuesday. The stock traded between $58.28 and $59.10 on volume of 455,601 shares traded. Analysts at Howard Weil have recently upgraded the company’s rating to “outperform” from “sector perform”. Shares of Hornbeck Offshore Services have gained approximately 70.0 percent year-to-date.

Find out more about Hornbeck Offshore Services including full access to the free equity report at:
www.RDInvesting.com/HOS

Neptune Technologies & Bioressources (NASDAQ: NEPT) shares increased 5.66 percent to close at $3.92 a share Tuesday. The stock traded between $3.83 and $4.21 on volume of 1.30 million shares traded. Analysts at H.C. Wainwright have recently initiated coverage on the company with a “buy” rating and a price target of $9.00. Shares of Neptune have gained approximately 95.0 percent year-to-date.

Find out more about Neptune including full access to the free equity report at:
www.RDInvesting.com/NEPT

Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN) shares declined 11.62 percent to close at $0.46 a share Tuesday. The stock traded between $0.46 and $0.43 on volume of 2.67 million shares traded. Analysts at H.C. Wainwright have recently initiated coverage on the company with a “buy” rating and a price target of $2.50. Shares of Rexahn Pharmaceuticals have gained approximately 48.0 percent year-to-date.

Find out more about Rexahn Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/RNN

Sanchez Energy Corp. (NYSE: SN) shares gained 0.32 percent to close at $21.98 a share Tuesday. The stock traded between $21.49 and $22.29 on volume of 305,240 shares traded. Analysts at Johnson Ricehave recently upgraded the company’s rating to “focus list” from “overweight”. Shares of Sanchez Energy have gained approximately 22.0 percent year-to-date.

Find out more about Sanchez Energy including full access to the free equity report at:
www.RDInvesting.com/SN

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com